From dsurkin@optonline.net Sun Nov 14 13:08:09 2010
Subject:Re: KeyB and Numa Organs

I don't follow the logic of DLQ's marketing. I count five organs using DLQ's DPS chip (with its embedded version of the Linux-based Beatrix software):
KeyB Duo
KeyB Solo
Diversi Duo
Diversi Solo
NumaOrgan

Aside: I have no inside information, but I'm guessing that Diversi and DLQ entered into a licensing agreement that gave Diversi exclusive rights to the U.S. market for some length of time. I also have no inside information about Joey D. becoming an investor in Diversi and later severing his relationship and dealing directly with DLQ.

The KeyB Solo, the Diversi Solo and the NumaOrgan arguably steal market share from each other. Why did DLQ do this? Regarding the KeyB Solo and the NumaOrgan, is DLQ giving up on the KeyB Solo and trying to take advantage of Fatar's world-wide distribution? Is DLQ planning to concede their potential clients to Fatar, and become mostly a technology-licensing company?